Invest now
Gland Pharma Balance Sheet Annual
BSE: 543245 | NSE: GLAND | ISIN: INE068V01023 | Sector: Biotechnology & Drugs2,841.90 -17.00 (-0.59%)Updated : 19 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 12,510.85 | 11,224.92 | 10,661.25 | 8,777.54 |
| Accumulated Depreciation Total | -2,204.01 | -1,424.66 | -1,044.91 | -723.09 |
| Cash Equivalents | 200.00 | 200.00 | - | 1,362.70 |
| Other Liabilities Total | 236.89 | 187.38 | 177.70 | 1.73 |
| Accrued Expenses | 184.46 | 146.87 | 38.98 | - |
| Long Term Debt | 69.93 | 77.66 | 106.54 | 3.26 |
| Common Stock Total | 16.48 | 16.48 | 16.47 | 16.47 |
| Other Equity Total | 468.82 | 37.83 | -17.56 | -9.69 |
| Other Current Assets Total | 0.14 | 0.10 | 100.77 | 7.91 |
| Prepaid Expenses | 40.95 | 39.24 | 38.46 | 13.82 |
| Total Assets | 12,510.85 | 11,224.92 | 10,661.25 | 8,777.54 |
| Current Portof LT Debt/ Capital Leases | 60.55 | 50.51 | 63.83 | 0.71 |
| Additional Paid- In Capital | 1,933.04 | 1,933.04 | 1,929.23 | 1,928.42 |
| Cash | 353.57 | 2,356.21 | 357.09 | 546.19 |
| Total Equity | 10,357.95 | 9,150.74 | 8,723.84 | 7,958.72 |
| Retained Earnings( Accumulated Deficit) | 7,939.61 | 7,163.39 | 6,795.70 | 6,023.52 |
| Total Common Shares Outstanding | 16.48 | 16.48 | 16.47 | 16.47 |
| Property/ Plant/ Equipment Total- Gross | 6,636.03 | 5,368.55 | 4,875.06 | 2,459.19 |
| Tangible Book Valueper Share Common Eq | 604.25 | 533.93 | 508.13 | 482.51 |
| Goodwill Net | 293.87 | 248.20 | 242.26 | - |
| Total Liabilities | 2,152.90 | 2,074.18 | 1,937.40 | 818.81 |
| Total Debt | 283.59 | 313.73 | 372.17 | 4.45 |
| Short Term Investments | 2,805.51 | 396.00 | 1,581.66 | 1,853.94 |
| Cashand Short Term Investments | 3,359.08 | 2,952.21 | 1,938.75 | 3,762.83 |
| Total Receivables Net | 2,341.21 | 2,058.06 | 1,890.83 | 1,138.06 |
| Notes Payable/ Short Term Debt | 129.81 | 156.07 | 167.12 | 0.00 |
| Deferred Income Tax | 214.38 | 214.81 | 220.12 | 84.20 |
| Accounts Receivable- Trade Net | 2,107.70 | 1,748.31 | 1,696.63 | 1,024.17 |
| Property/ Plant/ Equipment Total- Net | 4,432.02 | 3,943.89 | 3,830.15 | 1,736.10 |
| Total Current Liabilities | 1,608.40 | 1,564.85 | 1,398.36 | 729.13 |
| Total Inventory | 1,785.41 | 1,733.33 | 1,676.33 | 1,978.19 |
| Accounts Payable | 833.87 | 820.41 | 862.69 | 587.35 |
| Other Currentliabilities Total | 399.71 | 390.98 | 265.75 | 141.07 |
| Total Long Term Debt | 93.23 | 107.15 | 141.22 | 3.74 |
| Intangibles Net | 108.62 | 105.70 | 112.22 | 11.66 |
| Other Long Term Assets Total | 98.28 | 85.63 | 107.21 | 43.48 |
| Note Receivable- Long Term | 51.28 | 58.56 | 69.76 | 85.48 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 7,526.79 | 6,782.94 | 5,645.15 | 6,900.81 |
| Capital Lease Obligations | 23.30 | 29.49 | 34.68 | 0.48 |
| Long Term Investments | - | 0.00 | 654.50 | 0.00 |
*All figures in crores except per share values
Gland Pharma Quick Links
Gland Pharma Dividend Gland Pharma Bonus Gland Pharma News Gland Pharma AGM Gland Pharma Rights Gland Pharma Splits Gland Pharma Board Meetings Gland Pharma Key Metrics Gland Pharma Shareholdings Gland Pharma Profit Loss Gland Pharma Cashflow Gland Pharma Q1 Results Gland Pharma Q2 Results Gland Pharma Q3 Results Gland Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,322.50+22.50(1.73%)
320.20+4.20(1.33%)
392.05+4.75(1.23%)
262.45-5.35 (-2.00%)
1,078.60-14.35 (-1.31%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.